Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announces it has entered into an agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging (EVI) of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide advanced solutions for the treatment of patients with coronary artery disease, the most frequent type of heart disease, affecting more than 300 million people worldwide. SpectraWAVE, based in Bedford, Massachusetts, was founded in 2017 and currently employs more than 70 people.
Read the full article: Philips Agrees to Acquire SpectraWAVE Inc. //
Source: https://www.globenewswire.com/news-release/2025/12/15/3205131/0/en/Philips-agrees-to-acquire-SpectraWAVE-Inc-advancing-next-generation-coronary-intravascular-imaging-and-physiological-assessment-with-AI.html